bengaluru
English, Hindi
Abhay is a Research Analyst at Euromonitor International. He is based in the company’s Bangalore office, where he provides qualitative and quantitative market research and insight covering industry and consumer trends in India.
Abhay specialises in insight into India's health and beauty and services industries, with a special interest in travel and consumer health. He regularly engages with clients to discuss data trends and market developments. He also leverages Euromonitor’s product claims and survey data to provide further understanding to clients about consumer behaviour.
The use of GLP-1 drugs, which is already exerting a significant impact on the US food and beverage market, is set to rise sharply around the world in 2026. Semaglutide, the active ingredient in drugs like Ozempic, goes off-patent in much of the world that year. This means that millions of people are going to change how they eat and drink in the coming years, with significant impacts on the food and drink industry.
The Chinese government’s Healthy China Initiative 2019-2030 presents an opportunity for food and beverage brands to innovate, be that through reformulating existing products with better-for-you ingredients, developing targeted offerings that address specific health needs, or enhancing transparency to highlight product benefits and build consumer trust.
This year’s Sweet and Snacks Expo in the US, hosted by the National Confectioners Association, showcased the industry’s enhanced innovation capabilities and refocus on providing value to the consumer. Sensorially stimulating formats, bold and beloved flavours, and purpose-driven dialogue were major takeaways from the show.